SR0737 103RD GENERAL ASSEMBLY

SR0737 LRB103 39201 MST 69348 r

SENATE RESOLUTION

WHEREAS, Cholangiocarcinoma (bile duct cancer) is a rare form of cancer that originates from the cells lining the bile ducts that play a key role in digestion; there are three types of this cancer, intrahepatic, extrahepatic, and perihilar; and

WHEREAS, Approximately 12,000 Americans are diagnosed each year with cholangiocarcinoma, with numbers increasing yearly, and the mortality rate has increased dramatically in the last decade; and

WHEREAS, Patients are typically diagnosed at a late stage due to the lack of a validated early method of detection; symptoms of jaundice, abdominal pain, itchy skin, and weight loss are symptoms that do not usually present until advanced disease progression; and

WHEREAS, Cholangiocarcinoma is a rare cancer; of the top eight deadliest cancers, seven are rare; rare cancers have a five-year survival rate under 50%, with the cholangiocarcinoma five-year survival rate being approximately 20%; and

WHEREAS, There is currently no cure for cholangiocarcinoma/bile duct cancer; and

WHEREAS, Kelly green is the color representing cholangiocarcinoma/bile duct cancer awareness; and

WHEREAS, Foundations, research and teaching hospitals, rare cancer advocate groups, and patient advocate groups from around the globe have joined together to recognize February 18, 2024 as World Cholangiocarcinoma Day; and

WHEREAS, Increased cholangiocarcinoma advocacy, awareness, research, and education will bring improved outcomes for patients in earlier detection and treatment and potential curative methods; therefore, be it

RESOLVED, BY THE SENATE OF THE ONE HUNDRED THIRD GENERAL ASSEMBLY OF THE STATE OF ILLINOIS, that we recognize February 18, 2024 as being World Cholangiocarcinoma Day.